Corine M. Beaufort
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Identification of Resistance Genes in Breast Cancer Cells Treated with Fulvestrant and Ribociclib via Retroviral Screening and Integration Site Sequencing.
Journal: Cells
Published: December 09, 2025
Longitudinal genome-wide aneuploidy measurements in circulating cell-free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer.
Journal: Molecular oncology
Published: November 10, 2025
Prognostic value of peri-operative circulating tumour DNA levels estimated by cell-free DNA methylation in patients with resectable colorectal liver metastases.
Journal: EBioMedicine
Published: October 21, 2025
Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker study.
Journal: EClinicalMedicine
Published: March 26, 2025
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial.
Journal: Nature medicine
Published: February 24, 2025
A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancer.
Journal: Breast cancer research : BCR
Published: November 22, 2024
Cell-free DNA aneuploidy score as a dynamic early response marker in prostate cancer.
Journal: Molecular oncology
Published: July 25, 2024
Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients.
Journal: Genes
Published: April 25, 2024
Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient.
Journal: Cancers
Published: November 24, 2023
A Multiplex Assay for Fast PIK3CA Hotspot Mutation Characterization in a Single Specimen by 3-Color Digital PCR Analysis.
Journal: The journal of applied laboratory medicine
Published: November 23, 2023
Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels.
Journal: Scientific reports
Published: March 27, 2023
Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer.
Journal: Breast cancer research and treatment
Published: December 16, 2022
Last Updated: 09/26/2026